Pulmonary Hypertension

個数:

Pulmonary Hypertension

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合、分割発送となる場合がございます。
    3. 美品のご指定は承りかねます。
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 552 p.
  • 言語 ENG
  • 商品コード 9780367385422
  • DDC分類 616.24

Full Description

Written by internationally recognized experts, Pulmonary Hypertension bridges the gap between pulmonology and cardiology to provide clinicians in both disciplines with knowledge of the signs, symptoms, diagnosis, and pharmacologic and surgical treatments for pulmonary hypertension (PH). Through the use of clinical trials, this ground-breaking text supplies a comprehensive review of both the primary and secondary clinical and investigative aspects of this condition.

Discussing controversies and concepts in PH diagnosis and management, this guide explores:


classification and epidemiology, pathology, pathogenesis, genetics, and diagnosis of PH

causes of the condition, such as idiopathic pulmonary arterial hypertension (IPAH)

PAH-complicating connective tissue diseases (CTD), congenital heart diseases, human immunodeficiency virus (HIV), and other disorders

the mechanisms, toxicities, and efficacy of therapeutic agents

the role of combination therapies, novel agents, and future directions

PH in specific patient populations such as pregnant and critically-ill patients in the ICU

Contents

1. Classification and Epidemiology of Pulmonary Hypertension. 2. Pathology of Pulmonary Hypertension. 3. Pathogenesis of Pulmonary Arterial Hypertension (PAH). 4. Animal Models of Pulmonary Hypertension. 5. Genetics of PAH. 6. Imaging of Pulmonary Hypertension. 7. Echocardiography of PAH. 8. Diagnosis and Hemodynamic Assessment of PAH. 9. Idiopathic PAH. 10. PAH Complicating Connective Tissue Diseases. 11. PAH in Congenital Heart Diseases. 12. PAH and HIV Infection. 13. Portopulmonary Hypertension. 14. Pulmonary Hypertension Complicating Schistosomiasis. 15. Hemolysis-Associated Pulmonary Hypertension. 16. Pulmonary Veno-Occlusive Disease and Pulmonary Capillary Hemangiomatosis. 17. Pulmonary Hypertension in Obstructive Lung Diseases. 18. Pulmonary Hypertension in Restrictive Lung Diseases. 19. Chronic Mountain Sickness. 20. Chronic Thromboembolic Pulmonary Hypertension. 21. Medical Treatment of PAH: Basic Therapy and Calcium Channel Blockers. 22. Medical Treatment of PAH: Prostacyclins. 23. Medical Treatment of PAH: Phosphodiesterase Inhibitors. 24. Medical Treatment of PAH: Endothelin Receptor Antagonists. 25. Medical Treatment of PAH: Combination Therapy, Novel Agents, Future Directions and Current Recommendations. 26. Atrioseptostomy in PAH. 27. Surgical Management of PAH. 28. Lung Transplantation for Pulmonary Hypertension: Who Is a Candidate and When to List? 29. Pregnancy and PAH. 30. Management of PAH in the ICU. 31. End Points and Clinical Trial Designs in PAH: Clinical and Regulatory Perspectives.